EVERCON 0.5

Evercon 0.5 mg Tablet is classified as an ‘anti-cancer’ medication. It is mainly utilized for the treatment of breast cancer, pancreatic cancer, lung cancer, and kidney cancer. Breast cancer arises in the breast cells that are stimulated by the female hormone estrogen. Pancreatic cancer refers to a malignant growth in the pancreas, typically originating in the cells that produce digestive juices and hormones that regulate blood sugar levels. Lung cancer involves the uncontrolled proliferation of abnormal cells in one or both lungs.

Evercon 0.5 mg Tablet contains ‘Everolimus’, which is part of the ‘kinase inhibitors’ class of medications. It functions by reducing the immune system’s activity, thereby preventing the rejection of transplanted organs. Additionally, it halts the action of an abnormal protein responsible for the proliferation of cancer cells, effectively inhibiting the spread of cancerous cells.

Follow your doctor’s prescription when taking Evercon 0.5 mg Tablet. It is recommended to continue taking the medication for the duration specified by your doctor based on your health conditions. Possible side effects include weakness, infections, sinus inflammation, cough, diarrhea, fever, fatigue, otitis media (ear infection), stomatitis (mouth inflammation), and upper respiratory tract infections. Most side effects associated with Evercon 0.5 mg Tablet do not necessitate medical intervention and typically resolve on their own. However, if side effects persist or worsen, consult your physician.

To effectively manage your condition, continue using Evercon 0.5 mg Tablet for the duration prescribed by your doctor. If you have a known allergy to Evercon 0.5 mg Tablet or any other medications, inform your doctor. Avoid taking Evercon 0.5 mg Tablet if you are pregnant or planning to become pregnant, as it may pose risks to the unborn child. Additionally, breastfeeding mothers should refrain from using Evercon 0.5 mg Tablet due to potential harm to the newborn.